11 – 20 of 28
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Letter: how to define remission in ulcerative colitis – histological remission should be considered. Authors' reply
- Contribution to journal › Letter
-
Mark
Long-term outcome of infliximab treatment in chronic active ulcerative colitis : a Swedish multicentre study of 250 patients
- Contribution to journal › Article
- 2016
-
Mark
Incidence, clinical presentation and mortality of liver cirrhosis in Southern Sweden : A 10-year population-based study
- Contribution to journal › Article
- 2014
-
Mark
Association between high dietary intake of the n-3 polyunsaturated fatty acid docosahexaenoic acid and reduced risk of Crohn's disease
- Contribution to journal › Article
-
Mark
Letter: European Medicines Agency recommendations for allergic reactions to intravenous iron-containing medicines
- Contribution to journal › Letter
- 2013
-
Mark
Infliximab as rescue therapy in hospitalised patients with steroid-refractory acute ulcerative colitis: a long-term follow-up of 211 Swedish patients
- Contribution to journal › Article
-
Mark
The management of iron deficiency in inflammatory bowel disease - an online tool developed by the RAND/UCLA appropriateness method
- Contribution to journal › Article
- 2012
-
Mark
High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia
- Contribution to journal › Article
- 2010
-
Mark
Clinical trial: colectomy after rescue therapy in ulcerative colitis-3-year follow-up of the Swedish-Danish controlled infliximab study
- Contribution to journal › Article
-
Mark
The epidemiology and clinical features of portal vein thrombosis : A multicentre study
- Contribution to journal › Article
